Compounders Research Compare

Pulsenmore Ltd. Ordinary Shares(PLSM)

Medical - Devices · Omer, HD

$2.18-0.03 (-1.38%)

Delayed quote: Oct 6, 2026, 3:47 PM EDT

About Pulsenmore Ltd. Ordinary Shares

Pulsenmore Ltd. specializes in delivering self-scanning ultrasound technology for distant medical diagnosis and health screening throughout Israel and Europe. Its primary offering is the Pulsenmore at-home ultrasound system, which consists of a portable ultrasound unit that attaches to a patient's smartphone. An accompanying mobile application then securely uploads diagnostic images to the cloud for review. Furthermore, a specialized clinician dashboard enables medical professionals to examine stored video recordings or provide real-time guidance during a scan. Founded in 2014, the company is headquartered in Omer, Israel.

Omer, HD

71 employees

www.pulsenmore.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Elazar Sonnenschein

View full financials

EV/FCF Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/FCF ratio is N/A as of 2026-10-06T19:53:33.652Z.

Stored calculation inputs

Calculation as of: 2026-10-06T19:53:33.652Z.

Quote observation: 2026-10-06T19:47:52.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 14,173,590
Total debt · period ending 2026-06-30: 11,624,115.57945
Cash · period ending 2026-06-30: 14,745,916.172650002
TTM free cash flow: N/A

FMP input reference: f9e30a8d320e3cb26c3b838953cbb8bfe3908fe2cbbcdc0c218fd5db8a33f332

Free Cash Flow|FCF Yield|P/FCF Ratio|EV/EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

PLSM EV/FCF Ratio Metrics

EV/FCF RATIO

N/A

PLSM Competitors' EV/FCF Ratio

Pulsenmore Ltd. Ordinary Shares

Current

Market Cap

$14.17M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Vyome Holdings, Inc.

Market Cap

$14.39M

EV/FCF Ratio

12.43x

TTM Avg

13.15x

3Y Avg

13.15x

5Y Avg

13.15x

Obsidian Therapeutics Inc.

Market Cap

$13.93M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Sintx Technologies, Inc.

Market Cap

$13.86M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Karyopharm Therapeutics Inc.

Market Cap

$14.86M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Pasithea Therapeutics Corp.

Market Cap

$14.87M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Optimi Health Corp.

Market Cap

$13.36M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Citius Pharmaceuticals, Inc.

Market Cap

$13.31M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IN8bio, Inc.

Market Cap

$13.14M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Cocrystal Pharma, Inc.

Market Cap

$15.24M

EV/FCF Ratio

N/A

TTM Avg

97.85x

3Y Avg

97.85x

5Y Avg

97.85x

NAME	MARKET CAP	EV/FCF RATIO	TTM	3Y	5Y
Pulsenmore Ltd. Ordinary Shares (PLSM)	$14.17M	N/A	N/A	N/A	N/A
Vyome Holdings, Inc. (HIND)vs ›	$14.39M	12.43x	13.15x	13.15x	13.15x
Obsidian Therapeutics Inc. (OBX)vs ›	$13.93M	N/A	N/A	N/A	N/A
Sintx Technologies, Inc. (SINT)vs ›	$13.86M	N/A	N/A	N/A	N/A
Karyopharm Therapeutics Inc. (KPTI)vs ›	$14.86M	N/A	N/A	N/A	N/A
Pasithea Therapeutics Corp. (KTTA)vs ›	$14.87M	N/A	N/A	N/A	N/A
Optimi Health Corp. (OPTH)vs ›	$13.36M	N/A	N/A	N/A	N/A
Citius Pharmaceuticals, Inc. (CTXR)vs ›	$13.31M	N/A	N/A	N/A	N/A
IN8bio, Inc. (INAB)vs ›	$13.14M	N/A	N/A	N/A	N/A
Cocrystal Pharma, Inc. (COCP)vs ›	$15.24M	N/A	97.85x	97.85x	97.85x

Cash Flow Valuation Comparison

EV/FCF

N/A

P/FCF

N/A

FCF Yield

N/A

Formula: EV/FCF = Enterprise Value / Free Cash Flow

EV/FCF vs P/FCF:

EV/FCF accounts for debt and cash through enterprise value
P/FCF only considers equity value
EV/FCF can be compared across companies with different debt levels
Both measure how the market values cash generation

EV/FCF Ratio Formula & Definition

EV/FCF = Enterprise Value / Free Cash Flow (TTM)

Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

Free Cash Flow FCF Yield P/FCF Ratio EV/EBITDA All Metrics